Kelly Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Hold
1,040
0.09% 63
2026
Q1
$304K Hold
1,040
0.08% 74
2025
Q4
$365K Hold
1,040
0.09% 61
2025
Q3
$336K Hold
1,040
0.09% 63
2025
Q2
$405K Hold
1,040
0.12% 53
2025
Q1
$452K Buy
1,040
+5
+0.5% +$2.01K 0.14% 50
2024
Q4
$382K Buy
+1,035
New +$433K 0.14% 47

Other funds holding ELV

Kelly Financial Group's ELV Position: Q2 2026 in Review

Kelly Financial Group held its Elevance Health (ELV) position steady in Q2 2026 at 1,040 shares worth $402K. The position accounts for 0.09% of the portfolio, ranked #63.

Kelly Financial Group first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $452K in Q1 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kelly Financial Group held 1,040 shares of Elevance Health worth $402K as of Q2 2026.
  • Kelly Financial Group left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.09% of Kelly Financial Group's portfolio in Q2 2026, its #63 holding.
  • Kelly Financial Group first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Kelly Financial Group's Elevance Health position peaked at $452K in Q1 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kelly Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.